Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Zhengye Biotechnology (ZYBT) Institutional Ownership

Zhengye Biotechnology logo
$0.88 -0.04 (-4.12%)
As of 01:13 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Zhengye Biotechnology (NASDAQ:ZYBT)

Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$1.75M
Number of
Institutional Sellers
(last 12 months)
0
Get ZYBT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zhengye Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ZYBT Institutional Buying and Selling by Quarter

Zhengye Biotechnology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026 XTX Topco Ltd59,286$68K0.0%+71.4%0.126%
2/11/2026 WINTON GROUP Ltd63,297$73K0.0%+193.8%0.134%
11/17/2025 Millennium Management LLC14,602$38K0.0%N/A0.031%
11/17/2025 Citadel Advisors LLC11,685$31K0.0%N/A0.025%
11/13/2025 WINTON GROUP Ltd21,547$56K0.0%N/A0.046%
8/14/2025 Jane Street Group LLC193,982$1.16M0.0%N/A0.411%
8/13/2025 Invesco Ltd.36,839$220K0.0%N/A0.078%
8/8/2025 Geode Capital Management LLC29,068$174K0.0%N/A0.062%


ZYBT Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Zhengye Biotechnology shares: Jane Street Group LLC ($1.16M), Invesco Ltd. ($220K), Geode Capital Management LLC ($174K), WINTON GROUP Ltd ($73K), XTX Topco Ltd ($68K), and Millennium Management LLC ($38K), and Citadel Advisors LLC ($31K).Learn more on Zhengye Biotechnology's institutional investors.

The following institutional investors have purchased Zhengye Biotechnology's stock in the last 24 months: Jane Street Group LLC ($193.98K), WINTON GROUP Ltd ($63.30K), Invesco Ltd. ($36.84K), Geode Capital Management LLC ($29.07K), XTX Topco Ltd ($24.70K), Millennium Management LLC ($14.60K), and Citadel Advisors LLC ($11.69K).

Institutional investors have bought a total of 374,170 shares in the last 24 months. This purchase volume represents approximately $1.75M in transactions.



This page (NASDAQ:ZYBT) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners